Albireo Pharma EV - Enterprise Value 2011-2026 | ALBO

Annual EV - Enterprise Value Albireo Pharma

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
426 M	439 M	222 M	203 M	228 M	7.1 M	12.1 M	964 M	1.25 B	1.12 B	684 M	-14.4 M	-54.6 M	-64.7 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.25 B	-64.7 M	387 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	4.15 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	6.3 M	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	1.24 B	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	174 M	-	-13.47 %	$ 169 M	France
Alpine Immune Sciences ALPN	7.99 M	-	-	$ 2.17 B	USA
ASLAN Pharmaceuticals Limited ASLN	16.7 M	-	-14.27 %	$ 1.7 M	Singapore
AstraZeneca PLC AZN	59.6 B	-	-	$ 96.9 B	Britain
CureVac N.V. CVAC	-376 M	-	-	$ 867 M	Germany
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	-4.92 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	686 M	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	5.18 B	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	-5.73 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	-1.76 M	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	-38.5 M	-	-34.95 %	$ 21.5 M	Germany
CRISPR Therapeutics AG CRSP	4.38 B	$ 49.98	-0.5 %	$ 4.49 B	Schweiz
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	11.4 M	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	-1.83 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	115 M	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	2.07 B	$ 31.11	3.85 %	$ 2.07 B	USA
Generation Bio Co. GBIO	68.7 M	-	-	$ 344 M	USA
IMV IMV	23.6 M	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Akouos AKUS	107 M	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	-2.16 M	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	248 M	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	-1.17 B	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	156 M	$ 14.78	0.41 %	$ 212 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	10.3 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Enlivex Therapeutics Ltd. ENLV	434 M	$ 0.68	-5.31 %	$ 31.1 M	Israel
Applied Genetic Technologies Corporation AGTC	4.35 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	9.53 M	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	-721 K	$ 2.85	-	$ 4.69 M	Israel
Forte Biosciences FBRX	280 M	$ 17.8	2.3 %	$ 230 M	USA
Esperion Therapeutics ESPR	1.16 B	$ 3.16	0.16 %	$ 657 M	USA
Eton Pharmaceuticals ETON	599 M	$ 31.55	-1.74 %	$ 849 M	USA
Aptose Biosciences APTO	36.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
AlloVir ALVR	-55.1 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	31 K	-	-	$ 28.6 M	USA